Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07158905 AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980) |
AV-1980R 20 µg | Alzheimer | Phase 1 | RECRUITING | En attente / non publié | Institute for Molecular Medicine | United States · Alzheimer's Research and Treatment Ce… | 2026-06-23 → 2029-10-15 | Ouvrir |
| NCT01747213 Bisnorcymserine in Healthy Adult Volunteers |
BNC | Alzheimer | Phase 1 | COMPLETED | En attente / non publié | National Institute on Aging (NIA) | United States · Harbor Hospital Center, Baltimore, Un… | 2013-01-29 → 2019-01-08 | Ouvrir |
| NCT06194799 ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extensi… |
ACP-204 | Alzheimer | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | ACADIA Pharmaceuticals Inc. | United States, Brazil, Bulgaria, Chile, Czechia, Fran… | 2024-04-23 → 2029-05 | Ouvrir |
| NCT07399171 Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer… |
HT-4253 | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Halia Therapeutics, Inc. | United Arab Emirates · Burjeel Medical City, Abu Dhab… | 2026-05-12 → 2028-07 | Ouvrir |
| NCT05988385 ESSENTIAL — The Effects of Successful OSA Treatment on Memory and AD Bi… |
Positive airway pressure | Alzheimer | Non applicable | RECRUITING | En attente / non publié | California Pacific Medical Center… | United States · Mount Sinai, New York, United States … | 2024-08-29 → 2028-05-31 | Ouvrir |
| NCT06335953 ALIGN: Aligning Medications With What Matters Most (Demonstration) |
ALIGN: Aligning Medications With … | Alzheimer | Non applicable | COMPLETED | En attente / non publié | Johns Hopkins University | United States · Johns Hopkins Community Physicians, B… | 2024-05-07 → 2025-10-18 | Ouvrir |
| NCT07216716 HART — Evaluating the Effectiveness of the Health App Recommendation To… |
HART — Evaluating the Effectivene… | Alzheimer | Non applicable | RECRUITING | En attente / non publié | University of Pittsburgh | United States · University of Pittsburgh, Pittsburgh,… | 2025-12-05 → 2026-11-30 | Ouvrir |
| NCT07589595 A Study of Donanemab (LY3002813) in Participants With Early Cognitive D… |
Donanemab | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Eli Lilly and Company | United States, Japan, South Korea, Taiwan · Axiom Bra… | 2026-05-20 → 2028-08 | Ouvrir |
| NCT07571161 Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Un… |
Donanemab | Alzheimer | Phase 3 | RECRUITING | En attente / non publié | Eli Lilly and Company | China · 2nd Affiliated Hospital Chongqing Medical Uni… | 2026-04-30 → 2030-04 | Ouvrir |
| NCT06847321 Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Dis… |
LHP588 | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Lighthouse Pharmaceuticals, Inc. | United States · Adams Clinic Harlem, New York, United… | 2025-02-17 → 2029-03-15 | Ouvrir |
| NCT04146545 CRx-D — CommunityRx-Dementia |
CRx-D — CommunityRx-Dementia | Alzheimer | Non applicable | COMPLETED | En attente / non publié | University of Chicago | United States · University of Chicago, Chicago, Unite… | 2019-12-16 → 2024-03-19 | Ouvrir |
| NCT01845883 Perceptual Decision Making Under Conditions of Visual Uncertainty |
Deep Brain Stimulation (DBS) | Parkinson | Non applicable | WITHDRAWN | En attente / non publié | University of California, Los Ang… | United States · Neuroscience Research Building, Los A… | 2013-04 → 2016-12 | Ouvrir |
| NCT06944522 exPDite-2 — A Study to Investigate the Efficacy and Safety of Bemdanepr… |
bemdaneprocel | Parkinson | Phase 3 | RECRUITING | En attente / non publié | BlueRock Therapeutics | United States, Australia, Canada · Banner Sun Health … | 2025-06-17 → 2032-03 | Ouvrir |
| NCT06952504 A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination Wit… |
Pembrolizumab | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Belgium… | 2025-05-22 → 2032-05-24 | Ouvrir |
| NCT06293118 The Effects of Ischemic Conditioning in Individuals With Parkinson's Di… |
Ischemic conditioning group | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Hospital Israelita Albert Einstein | Non communiqué | 2026-10-01 → 2028-09-01 | Ouvrir |
| NCT06189170 Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Pati… |
KP405 | Parkinson | Phase 1 | COMPLETED | En attente / non publié | Kariya Pharmaceuticals | United Kingdom · MAC, Manchester, United Kingdom | 2024-08-01 → 2026-06-15 | Ouvrir |
| NCT06154356 Action Observation and Motor Imagery Therapy in Parkinson's Disease |
Action Observation and Motor Imag… | Parkinson | Non applicable | RECRUITING | En attente / non publié | Karamanoğlu Mehmetbey University | Turkey (Türkiye) · Karaman Training and Research Hosp… | 2023-12-14 → 2026-12 | Ouvrir |
| NCT04368858 DETECACTI — Towards the Use of Instrumented Tests for Screening the Ris… |
DETECACTI — Towards the Use of In… | Parkinson | Non applicable | COMPLETED | En attente / non publié | University Hospital, Clermont-Fer… | France · Chu Clermont Ferrand, Clermont-Ferrand, Fran… | 2020-08-28 → 2022-11-16 | Ouvrir |
| NCT06209502 Quality-of-Life Index (Q-Index) |
Quality-of-Life Index (Q-Index) | Parkinson | À vérifier | COMPLETED | En attente / non publié | Koios Care | Belgium · AZ Delta, Department of Neurology, EC refer… | 2023-11-01 → 2025-08-14 | Ouvrir |
| NCT07748962 Decoding the Neural Mechanisms Underlying Postural Instability and Gait… |
Decoding the Neural Mechanisms Un… | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | The Cleveland Clinic | United States · Cleveland Clinic, Cleveland, United S… | 2026-09-18 → 2027-04-18 | Ouvrir |
| NCT07749261 Gut Microbiota and Tryptophan Metabolites in Parkinson's Disease |
Gut Microbiota and Tryptophan Met… | Parkinson | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Ningxia Medical University | China · Laizhou People's Hospital, Laizhou, China | 2026-08-20 → 2026-11-20 | Ouvrir |
| NCT06049212 TroFuse-008 — Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in C… |
Sacituzumab Tirumotecan | Parkinson | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | Japan · Aichi Cancer Center ( Site 0006), Nagoya, Jap… | 2023-10-26 → 2027-01-29 | Ouvrir |
| NCT07308418 The Influence of Vibrotactile Stimulation on Self-selected Walking Spee… |
Vibrotactile feedback during walk… | Parkinson | Non applicable | COMPLETED | En attente / non publié | Magnes AG | Switzerland · Magnes AG, Zurich, Switzerland | 2026-01-10 → 2026-03-18 | Ouvrir |
| NCT07174310 PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (I… |
Prasinezumab | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Australia, Austria, Brazil, Canada, Ch… | 2025-11-24 → 2031-06-30 | Ouvrir |
| NCT06841354 A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy an… |
Sacituzumab Tirumotecan | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Belgium, Brazil,… | 2025-03-16 → 2030-05-18 | Ouvrir |